August 30 | 2023

2cureX launches its first two IndiTreat® products CE-marked under the new IVD Regulation

Read more
November 1 | 2022

Invitation to 2cureX Strategy Deep-Dive

Read more
September 29 | 2022

2cureX terminates liquidity provision service

Read more
June 1 | 2021

Management exercise all warrants within the framework of the 2018 incentive program

Read more
May 11 | 2021

Warrants of series TO1 were subscribed to approximately 96.75 percent and 2cureX AB receives approximately SEK 31.40 million.

Read more
May 11 | 2021

Teckningsoptioner av serie TO1 tecknades till cirka 96,75 procent och 2cureX AB tillförs cirka 31,40 MSEK

Read more
May 5 | 2021

Sista dag för handel med teckningsoptionerna av serie TO1 i 2cureX AB är idag, den 5 maj 2021

Read more
April 23 | 2021

Teckningskursen för utnyttjande av teckningsoptioner av serie TO1 i 2cureX AB har fastställts till 13,22 SEK och teckningsperioden inleds den 26 april 2021

Read more
April 23 | 2021

The exercise price for the warrants of series TO1 in 2cureX AB has been determined to SEK 13.22 and the subscription period starts April 26, 2021

Read more
August 4 | 2020

Första dag för handel med teckningsoptioner av serie TO1

Read more
August 4 | 2020

First day for trading in TO1 series warrants

Read more
July 13 | 2020

Avstämningsdag för tilldelning av teckningsoptioner av serie TO1 bestämd till den 17 juli 2020

Read more
July 13 | 2020

Record date for allotment of warrants of series TO1 is set to July 17, 2020

Read more
July 6 | 2020

2cureX har genomfört en riktad nyemission om cirka 40 MSEK som blev kraftigt övertecknad

Read more
July 6 | 2020

2cureX completes a heavily oversubscribed directed issue of approximately SEK 40 million

Read more
July 6 | 2020

2cureX AB intends to carry out a directed issue of units

Read more
July 6 | 2020

2cureX AB avser att genomföra en riktad nyemission av units

Read more
June 27 | 2019

Last day of trading in BTA 1 in 2cureX AB

Read more